Atomoxetine

• Antidepressants
• Central Nervous System Agents
• ATC:N06BA09

• Strattera
• Tomoxetina [Spanish]
• Tomoxetine
• Tomoxetine [Inn]
• Tomoxetinum [Latin]

• No information avaliable

C₁₇H₂₁NO

http://www.rxlist.com/cgi/generic3/strattera.htm

Atomoxetine FDA

No information avaliable

255.355 g/mol

No information avaliable

No information avaliable

Solid

4.656

Capsule

For the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).

Atomoxetine is an amphetamine used to treat ADD/ADHD in children and adults. Amphetamines are non-catecholamine sympathomimetic amines with CNS stimulant activity. It increases motor activity and mental alertness, and reduces drowsiness and a sense of fatigue, decreasing motor restlessness and improves one's ability to focus. Peripheral actions include elevation of systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action. There is neither specific evidence which clearly establishes the mechanism whereby amphetamine produces mental and behavioral effects in children, nor conclusive evidence regarding how these effects relate to the condition of the central nervous system. Atomoxetine activates the brain stem arousal system and cortex to produce its stimulant effect.

No information avaliable

No information avaliable

Humans and other mammals